Poliomyelitis Completed Phase 4 Trials for Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) (DB10787)

Back to Poliomyelitis

Also known as: Polio / Acute poliomyelitis, unspecified / Acute unspecified poliomyelitis / Polio acute / Acute poliomyelitis / Poliomyelitis NOS / Acute poliomyelitis (disorder) / Epidemic acute poliomyelitis (disorder) / Heine-Medin disease / Poliomyelitis (acute) / Poliomyelitis acute

Indication	Status	Phase
DBCOND0013769 (Poliomyelitis)	Completed	4

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00802867	Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™	Prevention	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (DB10788) Bordetella pertussis fimbriae 2/3 antigen (DB10790) Bordetella pertussis pertactin antigen (DB10789) Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) (DB10787) Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584)